Literature DB >> 16142886

Chondrocalcinosis secondary to hypomagnesemia in Gitelman's syndrome.

Hang-Korng Ea1, Anne Blanchard, Maxime Dougados, Christian Roux.   

Abstract

Chondrocalcinosis can be associated with hyperparathyroidism, hemochromatosis, hypophosphatasia, and hypomagnesemia. Gitelman syndrome (GS), an inherited disorder due to loss of function mutations of the gene encoding the distal convoluted tubule Na-Cl cotransporter (NCCT), is characterized by hypokalemia metabolic alkalosis, hypomagnesemia, and hypocalciuria. A 53-year-old man, with history of recurrent joint effusions and pains affecting knees and wrists, had transient episodes of muscle pain, weakness, cramping, and fatigue over a one-year period. Laboratory tests showed hypokalemia, metabolic alkalosis, hypocalciuria, and hypomagnesemia related to genetically proven GS. Radiographs of affected joints revealed calcium pyrophosphate dihydrate deposition. This observation points out the necessity to look for Mg depletion (and especially GS) in the biological investigation of chondrocalcinosis. Additionally, the association between GS (NCCT inactivation) and high bone mineral density provides a new insight into the possible role of thiazides in osteoporosis management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142886

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Calcium Pyrophosphate Deposition Disease.

Authors:  Ann K Rosenthal; Lawrence M Ryan
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

Review 2.  Magnesium disorders can cause calcium pyrophosphate deposition disease: A case report and literature review.

Authors:  Akanksha Joshi; Chokkalingam Siva
Journal:  Eur J Rheumatol       Date:  2017-08-29

Review 3.  The long-term complications of the inherited tubulopathies: an adult perspective.

Authors:  Maryam Khosravi; Stephen B Walsh
Journal:  Pediatr Nephrol       Date:  2014-02-25       Impact factor: 3.714

4.  [Osteoarthritis in hereditary metabolic diseases].

Authors:  J Zwerina; T Dallos
Journal:  Orthopade       Date:  2010-06       Impact factor: 1.087

Review 5.  [Osteoarthritis in hereditary metabolic diseases].

Authors:  J Zwerina; T Dallos
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

Review 6.  Calcium pyrophosphate deposition (CPPD) in a liver transplant patient: are hypomagnesemia, tacrolimus or both guilty? A case-based literature review.

Authors:  Simon Cadiou; Antonia Le Gruyer; Baptiste Giguet; François Robin; Morgane Milin; Xavier Guennoc; Pascal Guggenbuhl; Marine De Saint-Riquier
Journal:  Rheumatol Int       Date:  2021-03-11       Impact factor: 2.631

7.  Case Report: Cervical chondrocalcinosis as a complication of Gitelman syndrome.

Authors:  Zahra Iqbal; Paul Mead; John A Sayer
Journal:  F1000Res       Date:  2016-05-12

8.  Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis.

Authors:  Chao Zeng; Jie Wei; Robert Terkeltaub; Tuo Yang; Hyon K Choi; Yi-Lun Wang; Dong-Xing Xie; David J Hunter; Yuqing Zhang; Hui Li; Yang Cui; Liang-Jun Li; Guang-Hua Lei
Journal:  Arthritis Res Ther       Date:  2017-10-24       Impact factor: 5.156

Review 9.  Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.

Authors:  Laura Nuñez-Gonzalez; Noa Carrera; Miguel A Garcia-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.